Insider · CIK 0001903889
Kelly T. McKee Jr.
Files at GOVX (GeoVax Labs, Inc.). First filing Dec 26, 2023, latest Aug 8, 2025.
In brief
Kelly T. McKee Jr. files SEC Form 4 as officer at GOVX (GeoVax Labs, Inc.). Since Dec 26, 2023, Kelly T. McKee Jr. has reported 2 open-market buys worth $3,242 and 0 open-market sells worth $0, the latest filed on Aug 8, 2025.
A track record needs three past buys with six months of prices behind them; Kelly T. McKee Jr. has 1, so none is measured yet.
The newest scored trade: bought $742 of GOVX on Aug 7, 2025, filed Aug 8, 2025, scored 29 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
GOVX: GeoVax Labs, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 29Weak | GOVXbuy GeoVax Labs, Inc. | $742 1,107 shares | +46% | +40% from low-79% from high | |
| 29Weak | GOVXbuy GeoVax Labs, Inc. | $2,500 6,944 shares | +24% | +22% from low-67% from high |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | GOVX GeoVax Labs, Inc. | AGrant or award Stock Optionderivative | +17,600 | $0.00 | $0 | 17,600 | Jun 22, 2026 |
| Aug 7, 2025 | GOVX GeoVax Labs, Inc. | POpen-market purchase Common Stock | +1,107 | $0.67 | $742 | 3,494 | Aug 8, 2025 |
| Jun 5, 2025 | GOVX GeoVax Labs, Inc. | AGrant or award Stock Optionderivative | +70,000 | $0.00 | $0 | 70,000 | Jun 6, 2025 |
| Dec 22, 2023 | GOVX GeoVax Labs, Inc. | POpen-market purchase Common Stock | +6,944 | $0.36 | $2,500 | 35,782 | Dec 26, 2023 |
Questions about Kelly T. McKee Jr.
Answered from the filings on this page, as of the latest one.
Is Kelly T. McKee Jr. buying or selling?
Not in the last 12 months. Kelly T. McKee Jr.'s latest open-market trade on SEC Form 4 was bought $742 of GOVX on Aug 7, 2025.
How did Kelly T. McKee Jr.'s past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kelly T. McKee Jr. has 1.
Where does Kelly T. McKee Jr. file Form 4?
Kelly T. McKee Jr. has filed Form 4 at GOVX (GeoVax Labs, Inc.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.